Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ADU-1805
i
Other names:
ADU-1805, ADU 1805, ADU1805
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Exelixis, Sairopa
Drug class:
SIRPA antagonist
Related drugs:
‹
RRx-001 (2)
BMS-986351 (1)
ALTA-002 (0)
BI 765063 (0)
BI 770371 (0)
DS-1103 (0)
IBC0966 (0)
LM-101 (0)
RRx-001 (2)
BMS-986351 (1)
ALTA-002 (0)
BI 765063 (0)
BI 770371 (0)
DS-1103 (0)
IBC0966 (0)
LM-101 (0)
›
Associations
News
Trials
Filter by
Latest
over1year
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (clinicaltrials.gov)
P1, N=90, Recruiting, Sairopa B.V. | Not yet recruiting --> Recruiting
over 1 year ago
Enrollment open • Metastases
|
Keytruda (pembrolizumab) • ADU-1805
over1year
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (clinicaltrials.gov)
P1, N=90, Not yet recruiting, Sairopa B.V.
over 1 year ago
New P1 trial • Metastases
|
Keytruda (pembrolizumab) • ADU-1805
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login